Zions Bancorporation’s United Therapeutics UTHR Stock Holding History

Zions Bancorporation’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$2.12K	Hold	6	–	–	﹤0.01%	788
2024 Q3	$2.15K	Sell	6 -2	-25%	-$676	﹤0.01%	788
2024 Q2	$2.55K	Hold	8	–	–	﹤0.01%	829
2024 Q1	$1.84K	Hold	8	–	–	﹤0.01%	837
2023 Q4	$1.76K	Hold	8	–	–	﹤0.01%	831
2023 Q3	$1.81K	Buy	+8	New	+$1.84K	﹤0.01%	820
2023 Q2	–	Sell	-3	Closed	-$672	–	913
2023 Q1	$672	Buy	+3	New	+$740	﹤0.01%	871
2022 Q3	–	Sell	-331	Closed	-$78K	–	1081
2022 Q2	$78K	Sell	331 -37	-10%	-$7.52K	0.01%	410
2022 Q1	$66K	Buy	+368	New	+$70.1K	0.01%	468
2019 Q2	–	Sell	-6	Closed	-$1K	–	972
2019 Q1	$1K	Hold	6	–	–	﹤0.01%	904
2018 Q4	$1K	Sell	6 -19	-76%	-$2.2K	﹤0.01%	457
2018 Q3	$3K	Buy	25 +19	+317%	+$2.35K	﹤0.01%	688
2018 Q2	$1K	Hold	6	–	–	﹤0.01%	444
2018 Q1	$1K	Sell	6 -7	-54%	-$889	﹤0.01%	523
2017 Q4	$2K	Hold	13	–	–	﹤0.01%	564
2017 Q3	$2K	Buy	+13	New	+$1.66K	﹤0.01%	1019
2017 Q2	–	Sell	-6	Closed	-$1K	–	731
2017 Q1	$1K	Sell	6 -9	-60%	-$1.36K	﹤0.01%	697
2016 Q4	$2K	Hold	15	–	–	﹤0.01%	782
2016 Q3	$2K	Hold	15	–	–	﹤0.01%	742
2016 Q2	$2K	Hold	15	–	–	﹤0.01%	732
2016 Q1	$2K	Buy	+15	New	+$1.9K	﹤0.01%	779

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Zions Bancorporation's UTHR Position: Q4 2024 in Review

Zions Bancorporation held its United Therapeutics (UTHR) position steady in Q4 2024 at 6 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #788.

Zions Bancorporation first reported a position in UTHR in Q1 2016 and has held it in 21 quarters since. The position peaked at $78K in Q2 2022. 672 funds tracked by Wall St. Rank hold UTHR as of Q4 2024.

Zions Bancorporation held 6 shares of United Therapeutics worth $2.12K as of Q4 2024.
Zions Bancorporation left its United Therapeutics share count unchanged in Q4 2024.
United Therapeutics made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #788 holding.
Zions Bancorporation first reported a position in United Therapeutics in Q1 2016 and has held it in 21 quarters since.
Zions Bancorporation's United Therapeutics position peaked at $78K in Q2 2022.
672 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.